Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Limited therapeutic options exist for advanced urological cancers, necessitating research into invasion and metastasis mechanisms.
• Progression to malignant growth is linked to dysregulated growth factors and their receptors.
• Fibroblast growth factors (FGFs) are key regulators of cell growth and differentiation, with implications in cancer progression.

Purpose of the Study:

• To review the role of FGF signaling pathways in urological cancers.
• To summarize the biological and clinical relevance of FGFs in prostate, bladder, kidney, and testicular cancers.

Main Methods:

• Literature review of studies on FGF signaling in urological malignancies.
• Analysis of FGFs' involvement in processes like extracellular matrix degradation and angiogenesis.
• Synthesis of current knowledge on FGFs in various urological cancers.

Main Results:

• FGFs, including acidic FGF (aFGF) and basic FGF (bFGF), are implicated in promoting tumor invasion and metastasis.
• FGFs induce metalloproteinases (MMPs) that degrade the extracellular matrix, facilitating cancer spread.
• While aFGF and bFGF are well-studied for their angiogenic properties, other FGFs also play significant roles in urological tumors.

Conclusions:

• FGF signaling is a critical factor in the progression of urological cancers.
• Targeting FGF pathways presents a potential therapeutic strategy for advanced urological malignancies.
• Further research into the diverse roles of FGF family members is warranted for improved cancer treatment.